Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Durable hematologic complete responses can be achieved with lenalidomide in AL amyloidosis.

× No keyword cloud information.

5 in total

Review 1. New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors: Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal: Curr Heart Fail Rep Date: 2016-12

2. Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial.

Authors: Shaji K Kumar; Suzanne R Hayman; Francis K Buadi; Vivek Roy; Martha Q Lacy; Morie A Gertz; Jacob Allred; Kristina M Laumann; Leif P Bergsagel; David Dingli; Joseph R Mikhael; Craig B Reeder; A Keith Stewart; Steven R Zeldenrust; Philip R Greipp; John A Lust; Rafael Fonseca; Stephen J Russell; S Vincent Rajkumar; Angela Dispenzieri
Journal: Blood Date: 2012-04-13 Impact factor: 22.113

3. Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT).

Authors: Akshata Pandit; Lai Wei; Luis Bustamante; Patrick Elder; William B S Falk; Megan Sell; Ashley Rosko; Don M Benson; Steven M Devine; Craig C Hofmeister; Yvonne A Efebera
Journal: Arch Hematol Blood Dis Date: 2019

4. Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis.

Authors: Joseph R Mikhael; Steven R Schuster; Victor H Jimenez-Zepeda; Nancy Bello; Jacy Spong; Craig B Reeder; A Keith Stewart; P Leif Bergsagel; Rafael Fonseca
Journal: Blood Date: 2012-02-13 Impact factor: 22.113

Review 5. Recent advances in the diagnosis and management of amyloid cardiomyopathy.

Authors: Petra Nijst; Wh Wilson Tang
Journal: Fac Rev Date: 2021-03-24

5 in total